Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marius Ringelstein

Showing results (81-90 of 116) with videos related to

Pageof 12
Sort By:
Nature Communications|December 20, 2019
CD8<sup>+</sup> T cell-mediated endotheliopathy is a targetable mechanism of neuro-inflammation in Susac syndromeCatharina C Gross, Céline Meyer, Urvashi Bhatia, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|January 24, 2023
Effects of the COVID-19 Pandemic on Patients With NMO Spectrum Disorders and MOG-Antibody-Associated Diseases: COPANMO(G)-StudyMartin W Hümmert, Franziska Bütow, Daria Tkachenko, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|October 9, 2023
The OSCAR-MP Consensus Criteria for Quality Assessment of Retinal Optical Coherence Tomography AngiographyRebecca Wicklein, Charmaine Yam, Christina Noll, et al.
Neurology|December 5, 2019
Longitudinal optic neuritis-unrelated visual evoked potential changes in NMO spectrum disordersMarius Ringelstein, Jens Harmel, Hanna Zimmermann, et al.
Brain : a Journal of Neurology|July 18, 2024
Broader anti-EBV TCR repertoire in multiple sclerosis: disease specificity and treatment modulationTilman Schneider-Hohendorf, Christian Wünsch, Simon Falk, et al.
Brain : a Journal of Neurology|July 12, 2025
Brain atrophy patterns in anti-IgLON5 diseaseSelina M Yogeshwar, Frederik Bartels, Thomas Grüter, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|June 28, 2024
Retinal Changes in Double-Antibody Seronegative Neuromyelitis Optica Spectrum DisordersFrederike C Oertel, Hanna G Zimmermann, Seyedamirhosein Motamedi, et al.
Neurology|July 2, 2026
Factors Associated With Disability Improvement and Worsening Independent of Attacks in Patients With AQP4-IgG+ NMOSD and MOGAD: A Multicenter Cohort StudyDaniel Engels, Patrick Schindler, Joachim Havla, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|October 23, 2018
Apheresis therapies for NMOSD attacks: A retrospective study of 207 therapeutic interventionsIngo Kleiter, Anna Gahlen, Nadja Borisow, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 3, 2017
Immunotherapies in neuromyelitis optica spectrum disorder: efficacy and predictors of responseJan-Patrick Stellmann, Markus Krumbholz, Tim Friede, et al.
Pageof 12

Showing results (81-90 of 116) with videos related to

Sort By:
Pageof 12
Nature Communications|December 20, 2019
CD8<sup>+</sup> T cell-mediated endotheliopathy is a targetable mechanism of neuro-inflammation in Susac syndromeCatharina C Gross, Céline Meyer, Urvashi Bhatia, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|January 24, 2023
Effects of the COVID-19 Pandemic on Patients With NMO Spectrum Disorders and MOG-Antibody-Associated Diseases: COPANMO(G)-StudyMartin W Hümmert, Franziska Bütow, Daria Tkachenko, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|October 9, 2023
The OSCAR-MP Consensus Criteria for Quality Assessment of Retinal Optical Coherence Tomography AngiographyRebecca Wicklein, Charmaine Yam, Christina Noll, et al.
Neurology|December 5, 2019
Longitudinal optic neuritis-unrelated visual evoked potential changes in NMO spectrum disordersMarius Ringelstein, Jens Harmel, Hanna Zimmermann, et al.
Brain : a Journal of Neurology|July 18, 2024
Broader anti-EBV TCR repertoire in multiple sclerosis: disease specificity and treatment modulationTilman Schneider-Hohendorf, Christian Wünsch, Simon Falk, et al.
Brain : a Journal of Neurology|July 12, 2025
Brain atrophy patterns in anti-IgLON5 diseaseSelina M Yogeshwar, Frederik Bartels, Thomas Grüter, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|June 28, 2024
Retinal Changes in Double-Antibody Seronegative Neuromyelitis Optica Spectrum DisordersFrederike C Oertel, Hanna G Zimmermann, Seyedamirhosein Motamedi, et al.
Neurology|July 2, 2026
Factors Associated With Disability Improvement and Worsening Independent of Attacks in Patients With AQP4-IgG+ NMOSD and MOGAD: A Multicenter Cohort StudyDaniel Engels, Patrick Schindler, Joachim Havla, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|October 23, 2018
Apheresis therapies for NMOSD attacks: A retrospective study of 207 therapeutic interventionsIngo Kleiter, Anna Gahlen, Nadja Borisow, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 3, 2017
Immunotherapies in neuromyelitis optica spectrum disorder: efficacy and predictors of responseJan-Patrick Stellmann, Markus Krumbholz, Tim Friede, et al.
Pageof 12